Find policies, billing codes, payers, states, and providers
CPT 90477: Live Oral Vaccine for Adenovirus Type 7
CPT code 90477 represents administration of a live oral vaccine product for adenovirus type 7, used to prevent respiratory and related illnesses caused by this serotype. Nationally, vaccine administration codes like 90477 are important for tracking immunization delivery, public health response, and billing for preventive services across ambulatory and public health settings. Payers commonly involved in coverage and claims for this service include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
This publication provides a concise overview of what CPT code 90477 covers, the typical clinical and service settings where it is used, and which major payers are relevant to claims and coverage patterns. Readers will find benchmarks and policy-relevant context for immunization coding, an outline of common modifiers and billing considerations, and clinical context for adenovirus type 7 vaccination programs. The summary is aimed at billing professionals, clinicians involved in immunization delivery, and policy analysts monitoring vaccine administration coding and payer coverage nationally.
Customize your policy alerts
Sign up for cpt 90477 policy alerts
Get alerted when payer policies referencing 90477 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 90477 describes administration of a live oral vaccine product intended to protect against adenovirus type 7, a pathogen that can cause respiratory illnesses and other clinical conditions. The code denotes the vaccine product itself delivered by oral route as a preventive immunization.
Service type: Vaccine administration — live oral vaccine product
Typical site of service: Outpatient clinic, public health clinic, or other ambulatory settings where vaccines are provided orally
Data not available in the input for associated taxonomies, ICD-10 diagnoses, or related codes.